Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Translational medicine: Mice and men show the way.

× No keyword cloud information.

12 in total

Review 1. Fragile X syndrome: the GABAergic system and circuit dysfunction.

Authors: Scott M Paluszkiewicz; Brandon S Martin; Molly M Huntsman
Journal: Dev Neurosci Date: 2011-09-21 Impact factor: 2.984

Review 2. Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications.

Authors: Evdokia Anagnostou; Robin Hansen
Journal: Curr Opin Pediatr Date: 2011-12 Impact factor: 2.856

3. GABA(B)-mediated presynaptic inhibition of excitatory transmission and synaptic vesicle dynamics in cultured hippocampal neurons.

Authors: J S Isaacson; B Hille
Journal: Neuron Date: 1997-01 Impact factor: 17.173

4. Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.

Authors: Elizabeth M Berry-Kravis; David Hessl; Barbara Rathmell; Peter Zarevics; Maryann Cherubini; Karen Walton-Bowen; Yi Mu; Danh V Nguyen; Joseph Gonzalez-Heydrich; Paul P Wang; Randall L Carpenter; Mark F Bear; Randi J Hagerman
Journal: Sci Transl Med Date: 2012-09-19 Impact factor: 17.956

Review 5. Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome.

Authors: Gül Dölen; Mark F Bear
Journal: J Physiol Date: 2008-01-17 Impact factor: 5.182

6. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice.

Authors: Daniela Tropea; Emanuela Giacometti; Nathan R Wilson; Caroline Beard; Cortina McCurry; Dong Dong Fu; Ruth Flannery; Rudolf Jaenisch; Mriganka Sur
Journal: Proc Natl Acad Sci U S A Date: 2009-02-10 Impact factor: 11.205

Review 7. Lessons from fragile X regarding neurobiology, autism, and neurodegeneration.

Authors: Randi J Hagerman
Journal: J Dev Behav Pediatr Date: 2006-02 Impact factor: 2.225

Review 8. Neurofibromatosis type 1: new insights into neurocognitive issues.

Authors: Maria T Acosta; Gerard A Gioia; Alcino J Silva
Journal: Curr Neurol Neurosci Rep Date: 2006-03 Impact factor: 5.081

Review 9. Fragile X syndrome: from molecular genetics to therapy.

Authors: C D'Hulst; R F Kooy
Journal: J Med Genet Date: 2009-09 Impact factor: 6.318

10. Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.

Authors: Christina Henderson; Lasani Wijetunge; Mika Nakamoto Kinoshita; Matthew Shumway; Rebecca S Hammond; Friso R Postma; Christopher Brynczka; Roger Rush; Alexia Thomas; Richard Paylor; Stephen T Warren; Peter W Vanderklish; Peter C Kind; Randall L Carpenter; Mark F Bear; Aileen M Healy
Journal: Sci Transl Med Date: 2012-09-19 Impact factor: 17.956

1 in total

Review 1. Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes.

Authors: Hansen Wang; Sandipan Pati; Lucas Pozzo-Miller; Laurie C Doering
Journal: Front Cell Neurosci Date: 2015-02-26 Impact factor: 5.505

1 in total